SQ
SurgBoardsQ&A
5,200+ expert questions · 11 subspecialty boards

Built by surgeons, for surgeons.

Master your board exam with clinical vignettes built around real guidelines — NCCN, ESMO, ESSO and more. Every answer explained. Every question mapped to your syllabus.

No credit card required · 50-question free trial

Created by Pablo Lozano Lominchar, MD, PhD, EBPSM · Surgical Oncologist, HGUGM / UCM Madrid

EUFEBS-SO
intermediate

A 51-year-old woman is evaluated for pseudomyxoma peritonei (PMP) of appendiceal origin confirmed on histology as low-grade mucinous adenocarcinoma. CT and diagnostic laparoscopy demonstrate a Peritoneal Cancer Index (PCI) of 16, disease confined to the abdomen, no extra-abdominal spread. Performance status ECOG 0. What is the most appropriate management?

AFOLFOX systemic chemotherapy as primary treatment
Cytoreductive surgery (CRS) + HIPEC aiming for CC-0 cytoreduction
CDebulking without HIPEC followed by intraperitoneal 5-FU
DPalliative colostomy for symptom management
EWatchful waiting with 6-monthly CT until radiological progression
Board Pearl: In low-grade appendiceal PMP, CRS + HIPEC with complete cytoreduction (CC-0) is the standard of care and the single strongest predictor of long-term survival (PSOGI consensus). PCI ≤20 is a soft threshold — completeness of cytoreduction, not PCI alone, determines operability.
Referenced to
NCCNESMOESSOPSOGIJGCA

5,200+

Questions

11

Boards

10

Specialties

Free

Trial

How it works

Built for how surgeons study

On the ward. Between cases. The night before the exam.

Board-Specific

Filter by your exact exam. ABS, FEBS, MCh, TCBC and more — every question mapped to the official syllabus.

Instant Feedback

Guideline-referenced explanations the moment you answer. Learn the reasoning, not just the key.

Weak Area Focus

The engine tracks your accuracy and automatically resurfaces the topics you keep missing.

Study Anywhere

Installs as a PWA on iPhone and Android. Full offline-friendly practice. No app store, no friction.

Live now

11 boards across 5 countries

One platform for every major surgical subspecialty certification.

US

ABS-CGSO

Complex General Surgical Oncology

EU

FEBS-SO

Surgical Oncology

EU

FEBS-HPB

Hepatopancreatobiliary Surgery

EU

FEBS-Colo

Coloproctology

EU

FEBS-Endo

Endocrine Surgery

EU

FEBS-Breast

Breast Surgery

EU

FEBS-ECS

Oesophagogastric Cancer Surgery

EU

FEBS-MBS

Metabolic & Bariatric Surgery

EU

FEBS-TS

Transplant Surgery

IN

MCh-SO

MCh / FNB Surgical Oncology

BR

SBCO

Cirurgia Oncológica (SBCO)

Read the exam guides

Free format, syllabus & preparation guides for every board.

Roadmap

Expanding globally

More boards in the pipeline. Get notified when yours launches.

DrNB-SOQ2 2026
JSGSQ3 2026
JSHBPSQ3 2026
CMO-SOQ4 2026
ABHS-SOQ1 2027

One email when your board goes live. No spam.

Pricing

Simple, transparent pricing

Start free. Upgrade when you're ready.

Free

$0trial

50 questions to start

Popular

3 Months

$100/3 months

Most popular

Monthly

$40/month

Full access

Annual

$300/year

Best value — save 37%

Cancel anytime · Local currency in Europe · VAT may apply

Your certification is coming.
Start today.

Join surgical consultants and fellows across Europe, North America, Australia and India preparing for subspecialty certification.

No credit card · 50-question free trial

FAQ

Frequently asked questions

What is SurgBoardsQ&A?+

SurgBoardsQ&A is a surgical board exam preparation platform with 5,200+ clinical vignette MCQs covering 11 subspecialty surgical certification exams, including ABS-CGSO (USA), FEBS-SO (Europe), FEBS-HPB, FEBS-Colo, FEBS-Endo, FEBS-Breast, FEBS-ECS, FEBS-MBS, FEBS-TS, MCh-SO (India), and SBCO (Brazil). All questions are referenced to current guidelines (NCCN, ESMO, ESSO, PSOGI).

Which surgical board exams does SurgBoardsQ&A cover?+

SurgBoardsQ&A currently covers: ABS-CGSO (American Board of Surgery — Complex General Surgical Oncology), FEBS-SO (Fellowship of the European Board of Surgery in Surgical Oncology), FEBS-HPB (Hepatopancreatobiliary Surgery), FEBS-Colo (Coloproctology), FEBS-Endo (Endocrine Surgery), FEBS-Breast, FEBS-ECS (Oesophagogastric Cancer Surgery), FEBS-MBS (Metabolic & Bariatric Surgery), FEBS-TS (Transplant Surgery), MCh-SO (India), and SBCO (Brazil). Additional boards are in development.

Who creates the questions on SurgBoardsQ&A?+

All questions are written by Dr. Pablo Lozano Lominchar, MD, PhD, EBPSM — a surgical oncologist specializing in peritoneal malignancy and retroperitoneal sarcoma at Hospital General Universitario Gregorio Marañón, Madrid, and Associate Professor of Surgery at the Universidad Complutense de Madrid.

Is there a free trial?+

Yes. SurgBoardsQ&A offers a free tier with 50 questions at no cost, with no credit card required. Pro access starts at $40/month or $300/year for unlimited questions across all boards.

Are the questions referenced to current guidelines?+

Yes. Every explanation cites the relevant guideline source: NCCN, ESMO, ESSO, PSOGI, JGCA, or the landmark RCT underpinning the answer. The question bank is updated when major guidelines change.